11.03MMarket Cap-131P/E (TTM)
1.0918High1.0200Low21.98KVolume1.0400Open1.0500Pre Close23.45KTurnover0.25%Turnover RatioLossP/E (Static)10.41MShares4.196552wk High-0.14P/B9.47MFloat Cap0.599952wk Low--Dividend TTM8.94MShs Float196.7835Historical High--Div YieldTTM6.84%Amplitude0.5990Historical Low1.0660Avg Price1Lot Size
PAVmed Stock Forum
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care
PAVmed's subsidiary, Veris Health, has been awarded a $1.8 million grant from the National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH). The two-year grant will fund research to optimize and validate the Veris Cancer Care Platform for medically underserved cancer patients, in partnership with an academic cancer center.
The ...
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million Nih Grant to Enhance Cancer Care
📊⚡️📊
$Dow Jones Industrial Average (.DJI.US)$ rose by 0.59% to a new record high, closing at 41,211.12. In contrast, the $S&P 500 Index (.SPX.US)$ fell by 1.39%, and the $Nasdaq Composite Index (.IXIC.US)$ dropped by 2.76%. Tech stocks faced significant pressure, contributing to the mixed market performance.
Key Drivers
1. Strong Performers: $UnitedHealth (UNH.US)$, $Johnson & Johnson (JNJ.US)$, and $Cisco (CSCO.US)$ l...
PR Newswire· 6 mins ago
The incubator, PMX, and medical device firm Hatch Medical, execute joint venture agreement to complete their development and commercialization, starting with PortIO
NEW YORK, March 21, 2024 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical de...
No comment yet